⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34462845 | 0.83 | KEAP1 (0.71) | — | |
| SCHEMBL12300212 | 0.80 | — | — | |
| SCHEMBL5105427 | 0.78 | — | — | |
| SCHEMBL2589275 | 0.78 | — | — | |
| SCHEMBL14718470 | 0.76 | KEAP1 (0.61) | — | |
| SCHEMBL27835672 | 0.76 | KEAP1 (0.61) | — | |
| SCHEMBL29024056 | 0.75 | KEAP1 (0.60) | — | |
| SCHEMBL11723431 | 0.75 | KEAP1 (0.60) | — | |
| SCHEMBL22493494 | 0.75 | KEAP1 (0.60) | — | |
| SCHEMBL15009038 | 0.75 | KEAP1 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1884513-A1 | PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME | Japan Tobacco, Inc. (JP) | 2008-02-06 | — | — | EP | claimed |
| US-20070032529-A1 | Pyrazole compounds and their use as antidiabetes agents | JAPAN TOBACCO INC. (JP) | 2007-02-08 | — | — | US | claimed |
| EP-3472155-B1 | DEUTERATED COMPOUNDS FOR TREATING PAIN | NEUFORM PHARMACEUTICALS INC (US) | 2022-03-16 | — | — | EP | disclosed |
| US-11111236-B2 | Method for preparing oxaspirocycle derivative, and intermediate thereof | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2021-09-07 | — | — | US | disclosed |
| US-20200330444-A1 | DEUTERATED COMPOUNDS FOR TREATING PAIN AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF | NEUFORM PHARMACEUTICALS INC (US) | 2020-10-22 | — | — | US | disclosed |
| US-20200308151-A1 | METHOD FOR PREPARING OXASPIROCYCLE DERIVATIVE, AND INTERMEDIATE THEREOF | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2020-10-01 | — | — | US | disclosed |
| EP-3689859-A1 | METHOD FOR PREPARING OXASPIROCYCLE DERIVATIVE, AND INTERMEDIATE THEREOF | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2020-08-05 | — | — | EP | disclosed |
| US-20130231334-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | SYNGENTA CROP PROTECTION LLC (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2563118-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | Syngenta Participations AG (CH) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134819-A1 | METHODS OF CONTROLLING NEONICOTINOID RESISTANT APHIDS | SYNGENTA PARTICIPATIONS AG (CH) | 2011-11-03 | — | — | WO | disclosed |
| EP-1884513-A1 | PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME | Japan Tobacco, Inc. (JP) | 2008-02-06 | — | — | EP | disclosed |
| US-20070032529-A1 | Pyrazole compounds and their use as antidiabetes agents | JAPAN TOBACCO INC. (JP) | 2007-02-08 | — | — | US | disclosed |